NCT04400864

Brief Summary

Non- alcoholic fatty liver disease (NAFLD) is one of metabolic syndrome manifestation, and has become the leading cause for cirrhosis and the need for liver transplantation. The Mediterranean diet showed in many trials its benefit in the treatment of the metabolic syndrome and NAFLD. The Paleolithic Diet includes meat, fish, fruits, vegetables, nuts and seeds and avoidance of processed food and most of carbohydrates. In some studies this diet seemed to decrease triglycerides levels and improve insulin resistance. The aim of this study is to evaluate the influance of the paleolithic diat for the treatment of NAFLD, as shown in the Mediterranean Diet.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 26, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

June 4, 2020

Status Verified

May 1, 2020

Enrollment Period

1.3 years

First QC Date

May 20, 2020

Last Update Submit

May 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in the severity of the fatty liver measured by ultrasound and elastography.

    Changes in fatty liver severity score according to ultrasound wave intensity analysis- light ; moderate ; severe.

    3 months

Secondary Outcomes (2)

  • Changes in HbA1C

    3 months

  • Changes in Triglycerides levels

    3 months

Study Arms (2)

Mediterranean Diet

EXPERIMENTAL

Nutritional guidelines based on the principals of the Mediterranean Diet

Other: Dietary intervention

Paleolithic Diet

EXPERIMENTAL

Nutritional guidelines based on the principals of thePaleolithic Diet

Other: Dietary intervention

Interventions

dietary counseling based on the principals pf the dietary intervention group.

Mediterranean DietPaleolithic Diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • NAFLD

You may not qualify if:

  • pregnancy
  • Chronic kidney disease
  • post transplant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rabin Medical Center

Petah Tikva, Israel

RECRUITING

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Amir Shlomai, MD

    Rabin Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amir Shlomai, MD

CONTACT

Hagit Lustigman, RD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of internal medicine department

Study Record Dates

First Submitted

May 20, 2020

First Posted

May 26, 2020

Study Start

December 30, 2019

Primary Completion

May 1, 2021

Study Completion

May 1, 2021

Last Updated

June 4, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations